James Xue
Vorstandsvorsitzender bei CANBRIDGE PHARMACEUTICALS INC.
Vermögen: 2 Mio $ am 30.04.2024
Aktive Positionen von James Xue
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Vorstandsvorsitzender | 30.01.2018 | - |
| Vorsitzender | 30.01.2018 | - | |
| Gründer | 30.01.2018 | - | |
CANbridge Life Sciences Ltd.
 CANbridge Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology CANbridge Life Sciences Ltd. produces biopharmaceutical products. It engages in the research and development of therapeutic drug treatment for critical medical condition. The company was founded by James Xue on June 12, 2012 and is headquartered in Chaoyang, China. | Vorstandsvorsitzender | 12.06.2012 | - |
| Vorsitzender | 12.06.2012 | - | |
| Gründer | 12.06.2012 | - | |
| Präsident | 12.06.2012 | - | |
| CANbridge Consulting LLC | Gründer | - | - |
| Präsident | - | - | |
Canbridge Pharmaceuticals, Inc. (United States)
 Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | Direktor/Vorstandsmitglied | - | - |
| Präsident | - | - | |
| Unternehmenssekretär | - | - | |
| China Alliance For Rare Diseases | Corporate Officer/Principal | - | - |
| Shanghai Foundation For Rare Disease | Corporate Officer/Principal | - | - |
| University of Michigan Medical School | Corporate Officer/Principal | 01.08.2017 | - |
| Peking University Health Science Center | Corporate Officer/Principal | 01.08.2017 | - |
| The BayHelix Group | Corporate Officer/Principal | - | - |
Karriereverlauf von James Xue
Ehemalige bekannte Positionen von James Xue
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von James Xue
| Peking University School of Pharmaceutical Sciences | Undergraduate Degree |
| Brown University | Doctorate Degree |
| University of California | Graduate Degree |
| University of Virginia Darden School of Business | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 9 |
| China | 6 |
| Cayman Islands | 2 |
Operativ
| Corporate Officer/Principal | 6 |
| Founder | 3 |
| President | 3 |
Sektoral
| Consumer Services | 7 |
| Health Technology | 5 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
CANbridge Life Sciences Ltd.
CANbridge Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology CANbridge Life Sciences Ltd. produces biopharmaceutical products. It engages in the research and development of therapeutic drug treatment for critical medical condition. The company was founded by James Xue on June 12, 2012 and is headquartered in Chaoyang, China. | Health Technology |
| CANbridge Consulting LLC | |
Canbridge Pharmaceuticals, Inc. (United States)
Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | Health Technology |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| China Alliance For Rare Diseases | |
| Shanghai Foundation For Rare Disease | |
| The BayHelix Group |
